Understanding Axial Spondyloarthritis

Hillary Norton, MD, discusses the unmet needs in the treatment of axial spondyloarthritis and provides community rheumatologists with management advice.

Hillary Norton, MD, enumerates the treatment options for axial spondyloarthritis, including nonpharmacologic methods, opioids, NSAIDs, and TNF inhibitors.

Hillary Norton, MD, considers the windows of opportunity in managing axial spondyloarthritis to prevent various comorbidities and discusses the goals of therapy.

Hillary Norton, MD, discusses the diagnosis of axial spondyloarthritis, namely the difficulties of accurate and timely identification, and considers possible comorbidities.

Hillary Norton, MD, discusses the epidemiology of axial spondyloarthritis.

Hillary Norton, MD, considers the differences between nonradiographic and radiographic axial spondyloarthritis and discusses the impact of these diseases on everyday life.

Atul A. Deodhar, MD, reacts to emerging interest in axial spondyloarthritis and shares considerations for improving how the condition is managed in the future.

Clinical expertise using various nonpharmacologic and pharmacologic therapies, including newer biologic agents, in the treatment of axial spondyloarthritis, and suggestions for ensuring treatment coverage to patients.

An overview of current clinical guidelines and treatment recommendations for patients with axial spondyloarthritis, as well as a discussion on the potential importance of an early diagnosis and proper treatment and a patient’s risk for disease progression.

Goals of therapy and considerations for using disease activity scores such as the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) to assess and monitor patients.

An expert in the management of axial spondyloarthritis explains how it differs from other rheumatologic conditions, highlights common comorbidities, and reacts to its overall burden on patients’ quality of life.

Atul A. Deodhar, MD, explains why axial spondyloarthritis is challenging to diagnose and reinforces the need for educational efforts to help raise awareness among patients and the healthcare community and improve how the condition is managed.